Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 11 of 11 for “"Antiplatelet therapy"”.
-
The Effect of Tranexamic Acid on Transfusion Requirement in Dual Antiplatelet-Treated Anemic Patients Undergoing Off-Pump Coronary Artery Bypass Graft Surgery
… (CABG). As these patients are frequently on dual antiplatelet therapy, the two coexisting conditions could potentially increase the risk of bleeding and transfusion. The aim of this study was to evaluate the effect of tranexamic acid (TA) on blood loss and transfusion in preoperatively anemic …
-
Comparing long-term antiplatelet strategies to prevent morbidity and mortality in patients with drug-eluting coronary stents
Background: The optimal long-term antiplatelet therapy (APT) that balances the benefit of preventing myocardial infarction (MI) with the risk of severe bleeding is unknown in patients greater than one year after drug-eluting stent (DES) placement. Methods: We modeled life expectancy (LE) using …
-
Clinical outcome and Predictive factors of Coronary aneurysm after Percutaneous Coronary Intervention
… favorable clinical courses with continuous dual-antiplatelet therapy (Ahn et al., 2010) although poor clinical outcomes including in-stent restenosis and stent thrombosis after drug-eluting stent (DES) implantation were increased with CAAs after DES implantation (James et al., 2009). In this …
-
Genotype- versus phenotype-directed personalization of antiplatelet treatment in Koreans with coronary artery disease undergoing coronary stenting
… of patients with HOPR at the baseline. Tailored antiplatelet therapy according to point-of-care genetic and phenotypic testing is feasible and effective in decreasing HOPR after 30 days.
-
Fibrinogen, platelet and factor XIII supplementation in cardiac surgery: In vitro and in vivo studies
… improved platelet aggregation independently of antiplatelet therapy (IV). Time-dependent changes in platelet concentrates were detected with impedance aggregometry in vitro (V). The results predicted with moderate accuracy changes in aggregation after addition of the platelet concentrates to …
-
ASSOCIATION BETWEEN ATRIAL SIZE AND CEREBROVASCULAR EVENTS: A RETROSPECTIVE, COHORT STUDY
… with a history of AF or receiving anticoagulant therapy were excluded. Only the first TTE of each calendar year was included in the analysis (index echocardiogram). LAE was categorized by LAVi as absent (≤34 mL/m2), mild (>34 and ≤41 mL/m2), moderate (>41 and ≤48 mL/m2), or severe (>48 mL/m2). …
-
Microfluidic Approaches to Thrombosis and Hemostasis: Towards a Patient-Specific Test of Antiplatelet Therapeutics and the Assessment of Coagulopathy in Hemophilic and Trauma Patients
… to in vivo or in vitro aspirin, a common antiplatelet therapy over collagen type I surfaces at venous shear rates. Utilizing the same flow assay, we also characterized mechanism-based resistance to aspirin conferred by non-steroidal anti-inflammatory drugs. Furthermore, we have also …
-
Structural basis for sulfatide recognition by Disabled-2
… in platelets, which can be further employed in antiplatelet therapy.
-
Development and experimental validation of a novel arterial thrombosis-on-a-chip microfluidic device
… ‘off-site’ activity can mask the efficacy of antiplatelet compounds, but these erroneous effects were removed by the addition of downstream EDTA-solution. I then showed that the EDTA-quenched design is sensitive to differences in concentration of eptifibatide, further supporting it as an …
-
Downstream Cangrelor versus upstream ticagrelor in patients with St-Segment elevation myocardial infarction
Background: Il pretrattamento con un inibitore del recettore P2Y12 può essere preso in considerazione nei pazienti con infarto miocardico con sopraslivellamento del tratto ST (STEMI) indirizzati ad una rivascolarizzazione miocardica percutanea (PCI). In questo contesto, dove l’assorbimento orale …